Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Adaptive Biotech (NASDAQ: ADPT) COO sells 57,180 shares in 10b5-1 plan
Julie Rubinstein, President and COO of Adaptive Biotechnologies (ADPT), sold 57,180 shares of common stock in open-market transactions in late March. These sales, conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 18, 2025, followed the exercise of stock options for 44,166 shares. After these transactions, Rubinstein directly holds 455,878 shares of the company’s common stock.